SCHEMBL26212252

SCHEMBL26212252

CCCC(NC(=O)OCCCCn1cnc2c(N)nc(F)nc21)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SERPINA3 P01011 1/20 0.47
▸ ADORA2A P29274 6/20 0.40
▸ ADORA1 P30542 5/20 0.40
▸ TMIGD3 P0DMS9 4/20 0.40
▸ ADORA2B P29275 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CTSL P07711 1/20 0.36
▸ FAAH O00519 3/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19575642 1.00 SERPINA3 (0.47) SERPINA3ADORA2AADORA1TMIGD3ADORA2B
SCHEMBL19575371 0.92 TMIGD3 (0.41) SERPINA3ADORA2AADORA1TMIGD3ADORA2B
SCHEMBL26212223 0.92 TMIGD3 (0.41) SERPINA3ADORA2AADORA1TMIGD3ADORA2B
SCHEMBL26212539 0.90 HDAC1 (0.42) SERPINA3ADORA2AADORA1TMIGD3ADORA2B
SCHEMBL19575639 0.90 HDAC1 (0.42) SERPINA3ADORA2AADORA1TMIGD3ADORA2B
SCHEMBL26212177 0.87 ADORA2A (0.49) ADORA2AADORA1ADORA2BALDH1A1SMN1; SMN2
SCHEMBL19574920 0.87 ADORA2A (0.49) ADORA2AADORA1ADORA2BALDH1A1SMN1; SMN2
SCHEMBL20975164 0.87 HDAC1 (0.43) SERPINA3ADORA2AADORA1TMIGD3ADORA2B
SCHEMBL26224146 0.84 ALDH1A1 (0.37) ADORA2AADORA1TMIGD3ALDH1A1HTT
SCHEMBL19575392 0.81 ALDH1A1 (0.39) ALDH1A1HTTFAAHNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452477-B1 ADENINE DERIVATIVES AS PROTEIN KINASE INHIBITORS B C I PHARMA (BE) 2023-09-13 — — EP disclosed
Send feedback